Innoviva Inc news

   Watch this stock
Showing stories 1 - 10 of about 86   

Articles published

INVA 12.52 -0.07 (-0.56%)
price chart
Here's Why Innoviva Inc. Lost 10% Today
Shares of Innoviva (NASDAQ:INVA), a biotechnology royalty company that develops respiratory therapeutics and is perhaps best known as GlaxoSmithKline's (NYSE:GSK) development partner for its multiple next-generation COPD and asthma products, fell ...
Overwhelming Majority Of Non-GSK Shareholders Support Sarissa Capital And ...  PR Newswire (press release)
Innoviva Announces Preliminary Results of Annual Meeting  Yahoo Finance
Activist Sarissa says Innoviva backed out of proxy settlement deal
Activist hedge fund Sarissa Capital Management LP said on Wednesday that U.S. respiratory drug company Innoviva Inc (INVA.O) reneged on a proxy settlement deal that was struck earlier in the day.
Innoviva Reneges On Accepted Deal With Sarissa Capital  PR Newswire (press release)
Innoviva Urges Shareholders to Vote “FOR” All of Innoviva's Value-Creating ...
BRISBANE, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (the “Company” or “Innoviva”) (NASDAQ: INVA) today called upon shareholders to make the clear choice to vote FOR the Company's Board of Directors (the “Board”).
State Board of Administration of Florida Retirement System Has $754000 ...  Sports Perspectives
Stocks With Major Move: Innoviva (NASDAQ:INVA), Tile Shop Holdings (NASDAQ ...  eMarketsDaily
Innoviva director vote drama hands last-minute loss to Sarissa
NEW YORK Shareholders of Innoviva Inc. handed a narrow victory to the U.S. respiratory drug company, according to a person close to the matter, as its fight against activist hedge fund Sarissa Capital saw several last minute twists and turns.
Innoviva Says It Fends Off Sarissa Dissidents  TheStreet.com
Sarissa Capital States: Innoviva Already Appears To Renege On Cost Cuts ...
GREENWICH, Conn., April 17, 2017 /PRNewswire/ -- Sarissa Capital Management LP made the following statement regarding its nomination of a minority slate to the Board of Directors of Innoviva, Inc. (NASDAQ: INVA) at its 2017 annual meeting to be held ...
Innoviva Board Recommends Shareholders Vote “FOR” All of Innoviva's ...  Business Wire (press release)
Sarissa Capital Urges Shareholders Of Innoviva, Inc.: Follow The ...
Innoviva spends approximately $25 million per year, or $1.8 million per employee, to simply collect royalties. This sum is an outrageous amount of money for a company with such a simple business.
Form DFAN14A Innoviva, Inc. Filed by: Sarissa Capital Management LP  StreetInsider.com
Innoviva, Inc. (NASDAQ:INVA)- News Alerts on Active Notes: Windtree ...  Seneca Globe
Innoviva Inc. (INVA) Plunges 10.2% on April 20
Innoviva Inc. (INVA) had a rough trading day for Thursday April 20 as shares tumbled 10.2%, or a loss of $-1.43 per share, to close at $12.59.
ISS Supports All Three Sarissa Capital Nominees For Innoviva Board
GREENWICH, Conn., April 10, 2017 /PRNewswire/ -- Sarissa Capital Management LP ("Sarissa") announced today that Institutional Shareholder Services Inc. ("ISS"), the leading independent proxy voting and corporate governance advisory firm, supports ...
Newman Ferrara LLP Announces Corporate Governance Investigation of Innoviva ...
Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Innoviva, Inc. (“Innoviva” or the “Company”) (NASDAQ:INVA focusing on potential breaches of fiduciary duty by the Company's Board of Directors ...
Buzzer within Traders Radar: Innoviva, Inc.'s (INVA)  Is stories
Innoviva Inc (INVA) Shares Bought by State Street Corp  Chaffey Breeze
Innoviva Announces $50 Million Partial Royalty Notes Redemption
Innoviva, Inc. (the “Company” or “Innoviva”) (INVA) today announced that on May 15, 2017, the next interest payment date under its non-recourse royalty notes due 2029 (the “Royalty Notes”), Innoviva will prepay $50 million in outstanding principal, ...
Sizzling Mover to Target: Innoviva, Inc. (INVA)  StandardOracle
How Does Innoviva, Inc. (INVA) Stack Up Right Now?  StockNewsJournal